GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
J

Japan Medical Dynamic Marketing 7600.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

305

-18.01%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥23.92bn

FY2017FY2026

Net income

¥263.1m

FY2017FY2026

Free cash flow

−¥1.75bn

FY2017FY2026

Shareholders' equity

¥25.40bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥23.92bn¥25.11bn¥23.18bn¥21.31bn¥19.19bn¥16.74bn¥18.08bn¥16.73bn¥14.81bn¥13.63bn
Gross profit¥12.74bn¥15.65bn¥14.76bn¥13.99bn¥12.99bn¥11.42bn¥12.80bn¥11.81bn¥10.64bn¥9.71bn
Research and development¥864.9m¥960.0m¥874.4m¥662.9m¥485.6m¥466.7m¥470.6m¥484.3m¥594.9m¥480.1m
Operating income¥574.2m¥1.56bn¥1.75bn¥2.02bn¥2.79bn¥2.17bn¥2.64bn¥2.23bn¥2.05bn¥1.91bn
Net income¥263.1m−¥461.8m¥1.27bn¥1.42bn¥2.14bn¥1.66bn¥2.16bn¥1.98bn¥1.43bn¥1.13bn
Diluted earnings per share9.98-17.5248.2954.0681.0963.0982.0675.2253.9942.83

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥35.68bn¥33.83bn¥31.49bn¥29.43bn¥27.34bn¥25.19bn¥24.97bn¥23.49bn¥20.87bn¥21.54bn
Cash and short-term investments¥3.11bn¥3.18bn¥2.32bn¥2.80bn¥2.59bn¥2.47bn¥2.51bn¥2.26bn¥2.46bn¥2.79bn
Total liabilities¥10.25bn¥9.09bn¥5.88bn¥6.14bn¥5.85bn¥6.48bn¥7.97bn¥8.26bn¥7.61bn¥9.25bn
Debt¥5.87bn¥3.29bn¥1.49bn¥1.87bn¥1.85bn¥3.09bn¥4.14bn¥4.50bn¥4.53bn¥6.34bn
Shareholders' equity¥25.40bn¥24.68bn¥25.51bn¥23.16bn¥21.39bn¥18.63bn¥16.93bn¥15.19bn¥13.23bn¥12.27bn
Shares outstanding26m26m26m26m26m26m26m26m26m26m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥205.6m¥1.05bn¥2.10bn¥2.19bn¥3.11bn¥2.60bn¥2.73bn¥2.37bn¥2.56bn¥2.04bn
Capital spending−¥1.96bn−¥1.55bn−¥1.80bn−¥1.32bn−¥1.59bn−¥1.37bn−¥1.79bn−¥2.09bn−¥1.02bn−¥1.08bn
Free cash flow−¥1.75bn−¥504.1m¥302.5m¥870.7m¥1.53bn¥1.23bn¥945.6m¥273.5m¥1.55bn¥961.1m
Dividends paid−¥396.9m−¥371.1m−¥344.0m−¥317.3m−¥290.2m−¥264.5m−¥238.0m−¥211.0m−¥185.1m−¥159.4m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥5.33bn¥5.99bn¥6.32bn¥5.69bn¥5.92bn¥6.66bn¥6.64bn¥5.77bn
Gross profit¥2.56bn¥3.01bn¥3.39bn¥3.04bn¥3.30bn¥3.61bn¥4.18bn¥3.37bn
Operating income−¥526.2m¥56.1m¥309.9m¥57.7m¥150.4m¥326.4m¥560.3m¥303.0m
Net income−¥417.8m−¥24.1m¥217.4m¥3.9m¥65.9m−¥1.34bn¥382.7m¥223.0m
Diluted earnings per share-15.85-0.918.250.152.50-50.8814.538.47
Total assets¥35.38bn¥35.68bn¥34.47bn¥32.68bn¥32.22bn¥33.83bn¥33.80bn¥31.16bn
Cash and short-term investments¥2.56bn¥3.11bn¥2.48bn¥2.18bn¥2.35bn¥3.18bn¥2.33bn¥2.26bn
Debt¥5.77bn¥5.70bn¥4.50bn¥4.26bn¥3.15bn¥3.28bn¥2.57bn¥2.43bn
Shareholders' equity¥24.81bn¥25.40bn¥25.12bn¥24.32bn¥23.96bn¥24.68bn¥26.70bn¥24.82bn

Growth per year

Compound annual rate

3 years5 years10 years
Revenue3.9%7.4%6.3%
Operating income-34.3%-23.3%-10.3%
Net income-43.0%-30.9%-10.5%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin57.9%61.1%63.0%66.0%
Operating margin4.3%6.3%8.4%10.4%
Net margin-0.4%2.7%4.9%6.7%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings56.0-27.812.714.011.129.728.831.020.321.6
Price to sales0.60.50.70.91.23.03.53.72.01.8

Dividends and splits

Per share, in the currency the company pays

Paid for 18 years. Last went ex-dividend on 30 Mar 2026.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year32.0014.0013.0012.0011.0010.009.008.00
  • 1.1-for-1 split · 28 May 2002
  • 1.2-for-1 split · 28 May 2001
  • 1.2-for-1 split · 26 May 2000
  • 1.1-for-1 split · 26 May 1999

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.